Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Castration-Resistant Prostate Cancer (mCRPC) × Abiraterone Acetate × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 60 Prostatic Neoplasms, Castration-Resistant 4 Metastatic Castration-resistant Prostate Cancer 3 Prostate Cancer Metastatic 2 Neoplasm Metastasis 2 Metastatic Castration-Resistant Prostate Cancer 2 Adenocarcinoma 2 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Stage II Prostate Adenocarcinoma 1 Sleep Initiation and Maintenance Disorders 1 Prostatic Diseases 1 Prostate Adenocarcinoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Oligometastatic Prostate Carcinoma 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasms by Site 1 Neoplasms 1 NSCLC Harboring NRG1 Fusion 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Hormone Refractory Prostate Cancer 1 Metastatic Castration-sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Male Urogenital Diseases 1 Genital Neoplasms, Male 1 Fatigue 1 Depression 1 Dementia 1

Interventions

sipuleucel-T 2 enzalutamide 2 gallium 68 PSMA-11 1 Vancomycin 1 Metronidazole 1 Docetaxel 1 Ciprofloxacin 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡